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Lower survival rate for patients under 30 years of age and surgically
treated for gastric carcinoma
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Department ofSurgery II, Faculty ofMedicine, Kyushu University, Fukuoka, Japan.
Summary We analysed data on 38 patients with gastric cancer aged 30 years and younger who were
surgically treated in the Department of Surgery II, Kyushu University Hospital, between 1965 to 1985. These
younger patients comprised 2.6% of the total 1,470 patients treated for gastric cancer during this 21-year
period. The durations and the kinds of symptoms in the preoperative period varied with the patient. In
patients under 30 years of age, the female patients predominated, and in addition, undifferentiated lesions were
more common than the differentiated type, tumours were larger, serosal invasion was more prominent,
lymphatic involvement was more common, tumours showed infiltrative growth and the rate of peritoneal
dissemination was higher. Consequently the survival rates for these younger patients were poor. Detection at
an early stage of the disease is mandatory if the survival rates of younger patients with gastric cancer are to
improve.
Gastric cancer is considered to be a disease of the middle
aged and elderly; indeed, the peak incidence is in patients
over age 50 years (Bedikian et al., 1979; Bloss et al., 1980). It
has been reported that only about 1-2% of all cases of
gastric cancer occur in individuals aged 30 years or younger
(Tso et al., 1987; Okamoto et al., 1988; Matley et al., 1988).
The prognosis in these young patients has shown con-
siderable variability, with the poor prognosis attributed to a
delay in the diagnosis (Matsusaka et al., 1976; Bedikian et
al., 1979; Bloss et al., 1980), and to a more aggressive course
of disease (Tamura & Curtiss, 1960; Tso et al., 1987). How-
ever, the published literature does not make clear whether
there are differences in the prognosis between the younger
and the older patients. This present retrospective analysis of
pathological factors in patients under age 30 years and with
gastric cancer was undertaken to document the experience at
a single institution, and to define the pathological charac-
teristics and prognosis in this particular young group.
Patients and methods
Patients
Between January, 1965 and April, 1985, 1,470 Japanese
patients with primary gastric cancer and no evidence of any
other malignancy underwent gastric resection in the Depart-
ment of Surgery II, Kyushu University Hospital, Fukuoka,
Japan. Thirty-eight (2.6%) were under 30 years of age. The
pathological diagnosis and classification were according to
the General Rules for the Gastric Cancer Study in Surgery
and Pathology in Japan (Japanese Research Society for Gas-
tric Cancer, 1981).
Statistical analysis
The BMDP Statistical Package program (BMDP; Los
Angeles, CA) for the IBM (Armonk, NY) 4381 mainframe
computer was used for all analyses (Dixon, 1988). The
BMDP P4F and P3S programs were used to perform the
chi-square test and the Mann Whitney test to compare data
on patients under 30 years of age with those of patients over
age 30. The BMDP PIL program was used to analyse sur-
vival rates by the Kaplan Meier method, and the generalised
Wilcoxon and the Mantel Cox tests to test for equality of the
survival curves. The level of significance was P<0.05.
Results
Symptoms
The period from onset of symptoms to the date of diagnosis
ranged from 1 month to 10 years (Table I). These patients
presented with a multitude of different symptoms, the most
common being epigastralgia, nausea and vomiting, loss of
appetite and weight loss (Table II).
Clinicopathologicalfactors
Table III shows the clinicopathological data on the 38
patients aged 30 years and younger and the 1,432 patients
over 30, all of whom underwent gastric resection. The 38
patients ranged in age from 19 to 30 years, the mean being
age 26.4 years and median 27 years. Women were affected
more commonly than men. There were significant differences
between the gastric cancer patients under 30 years of age and
those over 30 with respect to sex, tumour size, histological
differentiation, serosal invasion, lymphatic involvement, his-
tological growth pattern and peritoneal dissemination. Speci-
fically, in patients under 30, the tumour was larger, the
undifferentiated type was more frequent, the depth of serosal
invasion was greater, the lymphatic involvement was more
common, histologically infiltrative growth was prominent and
the rate of peritoneal dissemination was higher.
Table I Duration of the disease from onset to admission
Duration Patients
0-1 month 9 (23.7%)
1-3 months 7 (18.4%)
3-6 months 8 (21.1%)
6-12 months 4 (10.5%)
1-2 years 3 (7.9%)
2-5 years 6 (15.8%)




Nausea and vomiting 15 (39.5%)
Loss of appetite 10 (26.3%)
Weight loss 8 (21.1%)
Dysphagia 5 (13.2%)
Back pain 5 (13.2%)
Melena 4 (10.5%)
Epigastrial fullness 3 (7.9%)
Upper gastrointestinal hemorrhage 3 (7.9%)
Correspondence: Y. Maehara, Department of Surgery II, Faculty of
Medicine, Kyushu University, Fukuoka 812, Japan.
Received 15 October 1990; and in revised form 10 January 1991.
'." Macmillan Press Ltd., 1991 Br. J. Cancer (1991), 63, 1015-10171016 Y. MAEHARA et al.
TableIII Clinicopathological characteristics ofgastriccancerinpatientsunder30yearsofage versusthose
over age 30 years
Under 30 years Over 30 years
Variable (n =38) (n = 1432) P value
Age 26.4±3.4* 58.7± 11.4 P<0.01
Sex Men 18 (47.4%) 962 (67.2%) P<0.05
Women 20 (52.6%) 470 (32.8%)
Tumour maximal diameter 8.5 ± 4.3* 6.9 ± 4.0 P<0.01
(cm)
Location of tumour Upper (C) 12 (31.6%) 345 (24.1%) NS
Middle (M) 16 (42.1%) 469 (32.7%)
Lower (A) 10 (26.3%) 618 (43.2%)
Gross appearance Superficial 5 (13.2%) 365 (25.5%) NS
Localised 7 (18.4%) 321 (22.4%)
Infiltrative 21 (55.2%) 622 (43.4%)
Unclassified 5 (13.2%) 124 (8.7%)
Histology Differentiated 5 (13.2%) 702 (49.0%) P<0.01
Undifferentiated 33 (86.8%) 732 (51.0%)
Prognostic serosal invasion Negative 10 (26.3%) 639 (44.6%) P< 0.05
Positive 28 (73.7%) 793 (55.4%)
Lymphatic involvement No invasion 8 (21.1%) 481 (33.6%) P<0.05
Minimal invasion 4 (10.5%) 227 (15.9%)
Intermediate invasion 10 (26.3%) 177 (12.4%)
Severe invasion 2 (5.3%) 148 (10.3%)
Unknown** 14 (36.8%) 399 (27.8%)
Vascular involvement No invasion 20 (52.6%) 792 (55.3%) NS
Minimal invasion 3 (7.9%) 128 (8.9%)
Intermediate invasion 0 (0%) 35 (2.4%)
Severe invasion 0 (0%) 18 (1.3%)
Unknown** 15 (39.5%) 459 (32.1%)
Histological growth pattern Expansive 2 (5.3%) 236 (26.5%) P<0.05
Intermediate 8 (21.1%) 401 (28.0%)
Infiltrative 28 (73.6%) 739 (51.6%)
Unknown** 0 (0%) 56 (3.9%)
Histological lymph node Negative 14 (36.8%) 567 (39.6%) NS
metastasis Positive 24 (63.2%) 865 (60.4%)
Peritoneal dissemination Negative 30 (78.9%) 1284 (89.7%) P< 0.05
Positive 8 (21.1%) 148 (10.3%)
Liver metastasis Negative 37 (97.4%) 1352 (94.4%) NS
Positive 1 (2.6%) 80 (5.6%)
Operative procedure Partial 21 (55.3%) 896 (62.6%) NS
Total 17 (44.7%) 536 (37.4%)
Curability Curative 21 (55.3%) 977 (68.2%) NS
Noncurative 17 (44.7%) 455 (31.8%)
NS, no significant difference; *mean ± standard deviation; **Unknown cases were excluded in statistical
analysis.
Survival rates
The median follow-up time at the time of analysis (July,
1989) was 9.7 years for the 465 survivors of the total 1,470
patients. Postoperative survival curves for patients under age
30 versus those over 30 are shown in Figure 1. The general-
ised Wilcoxon and the Mantel Cox tests between the survival
curves showed a statistically significant difference (P<0.01).
The 10-year survival rate was 30.5% for those under 30 and
50.3% for patients over 30.
Discussion
Gastric cancer occurs most commonly in individuals aged 50
to 70 years (Bloss et al., 1980) and the incidence of gastric
cancer in younger patients has been consistent with gastric
cancer in several series (Tso et al., 1987; Matley et al., 1988;
Okamoto et al., 1988). 2.6% of our patients with gastric
cancer were under 30 years of age, findings consistent with
the data of Matley and colleagues (1988). While it has been
reported that the antral region was more often involved
(Bloss et al., 1980; Tso et al., 1987), in our patients we found
no tendency for involvement of any specific region of the
stomach (Matsusaka et al., 1976). The female predominance
noted in the present series was also seen by Tso et al. (1987).
A high frequency of pregnancy in young women with gastric
cancer has been noted (Bloss et al., 1980; Matley et al.,
1988). As pregnancy most often occurs in this age group, the
association could be fortuitous (Matley et al., 1988). The
presence of estrogen receptors and intracytoplasmic estradiol
in a proportion of patients of all ages fails to explain the
preponderance of the female sex among these young cancer
patients (Nishi et al., 1987). Marked differences were noted
when we compared the histological features of our younger
versus the older patients (Tso et al., 1987; Matley et al., 1988;
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Figure 1 Survival curves for gastric cancer patients under 30
years of age versus those over 30. There were 38 patients under
30 years of age (lighter line) and 1,432 patients over age 30
(darker line). Survival of the younger patients was significantly
shorter than that of the older patients (P<0.01).SURVIVAL RATE OF YOUNGER GASTRIC CARCINOMA PATIENTS 1017
Undifferentiated type cancer, which is relatively more fre-
quent in women and in younger patients, typically results in
a shorter survival than is seen in cases of the differentiated
type (Tso et al., 1987). We found herein that the shorter
survival time in patients under age 30 was related to larger
tumour size, extended serosal invasion and increased rate of
peritoneal dissemination, all ofwhich are significant prognos-
tic factors (Iriyama et al., 1986; Maruyama, 1987; Maehara
et al., 1991a,b). The predominance of these factors represents
distinct characteristics of the undifferentiated type of lesion
(Koga et al., 1978; Sugano et al., 1982).
The duration between the onset of symptoms and the
diagnosis varied with the patient. The diagnosis was made
late in these patients; their younger age was considered to be
the major deterrent to making an early diagnosis (Matsusaka
et al., 1976; Bloss et al., 1980; Okamoto et al., 1988). Other
investigators have reported that the short duration of symp-
toms before the diagnosis correlated with the patients wide-
spread disease and subsequent short survival (Tamura &
Curtiss, 1960; Tso et al., 1987). This was explained as being
indicative of rapid growth and dissemination of the tumour.
Upper gastrointestinal tract endoscopy was the most effective
diagnostic tool and thus should be used in evaluating any
young adult with either a gastric ulcer or persistent gastric
symptoms (Bloss et al., 1980). Endoscopic biopsy led to a
diagnosis of cancer in all these patients.
As residual or occult tumour cells may grow rapidly during
the p1ostoperative period (Schabel, 1975; Gunduz et al.,
1979), the potential for controlling the residual tumour is
significantly reduced by delaying adjuvant chemotherapy fol-
lowing surgery. Therefore, adjuvant chemotherapy is rec-
ommended for patients who undergo a potentially curative
gastric resection and who have either a minimum residual
disease or a known risk of recurrence, as well as for those
patients undergoing a noncurative resection (Inokuchi et al.,
1984).
Gastric cancer in younger patients has been demonstrated
to be infrequent, although it is a lethal disease (Tso et al.,
1987). It has been pointed out that the prognosis in young
patients with a gastric cancer was no worse than that in the
population as a whole, if the lesion was detected before the
cancer reached the subserosa (Bedikian et al., 1979; Mori et
al., 1985). The cure rate for cancer of the stomach in young
adults seems to depend entirely on an early diagnosis. Upper
gastrointestinal radiographs and endoscopic photographs
should be obtained when younger patients admitted to hos-
pital have symptoms related to gastrointestinal disorders.
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